Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of life.
Younes H, Ademi B, Tsakiris E, Feng H, Pandey AC, Mekhael M, Noujaim C, Lim C, Dagher L, Hajjar AHE, Bidaoui G, Bsoul M, Assaf A, Rao S, Mahnkopf C, Shamaileh G, Kreidieh O, Hassan A, Liu Y, Jia Y, Polo FT, Marrouche NF, Donnellan E. Younes H, et al. Among authors: mahnkopf c. J Interv Card Electrophysiol. 2024 Sep 12. doi: 10.1007/s10840-024-01916-6. Online ahead of print. J Interv Card Electrophysiol. 2024. PMID: 39264394
Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial.
Zhao Y, Krupadev V, Dagher L, Mahnkopf C, Sohns C, Sehner S, Suling A, Sanders P, Boersma L, Schunkert H, Wegscheider K, Brachmann J, Marrouche NF. Zhao Y, et al. Among authors: mahnkopf c. J Interv Card Electrophysiol. 2021 Sep;61(3):609-615. doi: 10.1007/s10840-020-00856-1. Epub 2020 Sep 4. J Interv Card Electrophysiol. 2021. PMID: 32888121 Clinical Trial.
Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trial.
Younes H, Sohns C, Akoum N, Feng H, Tsakiris E, Hajjar AHE, Donnellan E, Pandey AC, Lim C, Bidaoui G, Mekhael M, Noujeim C, Chouman N, Assaf A, Shamaileh G, Polo FT, Bsoul M, Dagher L, Kreidieh O, Rao S, Sommer P, Forkmann M, Brachmann J, Marrouche N, Mahnkopf C. Younes H, et al. Among authors: mahnkopf c. J Interv Card Electrophysiol. 2024 Jun 7. doi: 10.1007/s10840-024-01831-w. Online ahead of print. J Interv Card Electrophysiol. 2024. PMID: 38848006
Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial.
Brachmann J, Sohns C, Andresen D, Siebels J, Sehner S, Boersma L, Merkely B, Pokushalov E, Sanders P, Schunkert H, Bänsch D, Dagher L, Zhao Y, Mahnkopf C, Wegscheider K, Marrouche NF. Brachmann J, et al. Among authors: mahnkopf c. JACC Clin Electrophysiol. 2021 May;7(5):594-603. doi: 10.1016/j.jacep.2020.11.021. Epub 2021 Feb 24. JACC Clin Electrophysiol. 2021. PMID: 33640355 Free article. Clinical Trial.
Atrial fibrosis progression in patients with no history of atrial fibrillation.
Dagher L, Shi H, Zhao Y, Mitlacher M, Schnupp S, Ajmi I, Forkmann M, Marrouche N, Mahnkopf C. Dagher L, et al. Among authors: mahnkopf c. J Cardiovasc Electrophysiol. 2021 Aug;32(8):2140-2147. doi: 10.1111/jce.15140. Epub 2021 Jul 12. J Cardiovasc Electrophysiol. 2021. PMID: 34191382
Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.
Sohns C, Zintl K, Zhao Y, Dagher L, Andresen D, Siebels J, Wegscheider K, Sehner S, Boersma L, Merkely B, Pokushalov E, Sanders P, Schunkert H, Bänsch D, Mahnkopf C, Brachmann J, Marrouche NF. Sohns C, et al. Among authors: mahnkopf c. Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008461. doi: 10.1161/CIRCEP.120.008461. Epub 2020 Sep 9. Circ Arrhythm Electrophysiol. 2020. PMID: 32903044 Free article. Clinical Trial.
Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design.
Marrouche NF, Greene T, Dean JM, Kholmovski EG, Boer LM, Mansour M, Calkins H, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Jais P, Sanders P, Brachmann J, Bax J, Dagher L, Wazni O, Akoum N; DECAAF II Investigators. Marrouche NF, et al. Among authors: mahnkopf c. J Cardiovasc Electrophysiol. 2021 Apr;32(4):916-924. doi: 10.1111/jce.14957. Epub 2021 Mar 2. J Cardiovasc Electrophysiol. 2021. PMID: 33600025 Clinical Trial.
Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial.
Akoum N, Mekhael M, Bisbal F, Wazni O, McGann C, Lee H, Bardsley T, Greene T, Dean JM, Dagher L, Kholmovski E, Mansour M, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Wells D, Jaïs P, Sanders P, Brachmann J, Bax JJ, Morrison-de Boer L, Deneke T, Calkins H, Sohns C, Marrouche N; DECAAF II investigators. Akoum N, et al. Among authors: mahnkopf c. Heart Rhythm. 2024 Sep 6:S1547-5271(24)03288-0. doi: 10.1016/j.hrthm.2024.08.062. Online ahead of print. Heart Rhythm. 2024. PMID: 39245248
44 results